Thermogenesis Holdings Inc: THMO specializes in technologies for cell and gene therapy. It was known as Cesca Therapeutics Inc. until 2019. It was founded in 1986 and its headquarters are in Rancho Cordova, California. The stock is trading at 2.65 as of me writing this but has a target of 8.5 according to multiple forecasts. Moreover, of the top 10 institutions owning THMO shares, 6 of them have increased their position, 2 have maintained and 2 have decreased their position. With the continued advancement of the CAR-TXpress platform that automates cell processing, Thermogenesis Holdings Inc. can efficiently produce high-value samples and significantly scale up their production. This will be instrumental for success in the emerging CAR-T immunotherapy market for the treatment of cancer.